We found that NER components (e.g., XPC, XPA and ERCC1) was up-regulated by the USP35-FUCA1 axis and we considered it an underlying mechanism for USP35-FUCA1 axis-mediated oxaliplatin resistance in CRC. Here, XPC is linked to colorectal carcinoma.